FDA Status
Not FDA-Approved
Russian bioregulator (SPIBG)
Claimed Benefits
- Neuroprotection & oxidative stress reduction
- Cognitive improvement
- Athletic adaptation support
Clinical Evidence
3
Human Trials
Clinical Evaluation
Highest Phase
Russian clinical evaluations report improved memory and attention in elderly patients, but no Western RCT verification exists.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations